Search Results - "Bryar, Julie M"

Diagnostic Performance of the (1→3)-β-d-Glucan Assay for Invasive Fungal Disease by Koo, Sophia, Bryar, Julie M., Page, John H., Baden, Lindsey R., Marty, Francisco M.

“…Background.Diagnosis of invasive fungal disease (IFD) is challenging, and it remains a significant cause of morbidity and mortality in immunocompromised…”
Get full text

Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis by Koo, Sophia, Bryar, Julie M, Baden, Lindsey R, Marty, Francisco M

“…Prognostic features of serum galactomannan (GM) remain poorly defined in patients with GM-positive invasive aspergillosis (GPA). We identified 93 patients with…”
Get full text

Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis by Kubiak, David W., PharmD, Bryar, Julie M., BA, McDonnell, Anne M., PharmD, Delgado-Flores, Jorge O., PharmD, Mui, Emily, PharmD, Baden, Lindsey R., MD, Marty, Francisco M

“…Abstract Background: Caspofungin is approved in the United States for empiric antifungal therapy for persistent febrile neutropenia (FN). There are limited…”
Get full text

Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies by Kallenberg, Marije H, Gill, Ritu R., MD, Factor, Rachel E., MD, Bryar, Julie M., BA, Rubin, Robert H., MD, Jacobson, Francine L., MD, MPH, Marty, Francisco M., MD

“…Rationale and Objectives The role of transthoracic needle biopsy (TTNB) in patients with hematologic malignancies, particularly in discriminating between…”
Get full text

Invasive fungal disease in patients treated for newly diagnosed acute leukemia by Hammond, Sarah P., Marty, Francisco M., Bryar, Julie M., DeAngelo, Daniel J., Baden, Lindsey R.

“…Invasive fungal disease (IFD) is a significant cause of morbidity and mortality in patients undergoing treatment for acute leukemia (AL). Antifungal…”
Get full text

Improving quality and safety of oncology patient care: Standardization of the post-clinic message triage process by Donohue, Caitlin C., Kaymakcalan, Marina, Elfiky, Aymen, Dalby, Carole Kathleen, Bryar, Julie M., Jacobson, Joseph O.

“…Abstract only 163 Background: Due to the rapidly increasing complexity of the treatment and management landscape of genitourinary oncology patients,the high…”
Get full text

Implementation of chemotherapy treatment plans (CTP) in a large comprehensive cancer center (CCC): The key roles of infrastructure and data sharing by Bryar, Julie M., Dalby, Carole Kathleen, Anastas, Susan, Brady, Lauren, Hassett, Michael J., Shulman, Lawrence N., Jacobson, Joseph O.

“…Abstract only 20 Background: ASCO recommends that prior to initiating chemotherapy, a synoptic CTP should be created. At a large CCC, there was no tool to…”
Get full text

Limitations of QOPI end-of-life (EOL) data use for purposes of accountability: Comparison of sample versus full cohort analysis by Dalby, Carole Kathleen, Catalano, Paul J., Donohue, Caitlin C., Bryar, Julie M., Norden, Andrew David, Kostka, Judith, Jacobson, Joseph O.

“…Abstract only 87 Background: Quality Oncology Practice Initiative (QOPI) retrospectively collects process measures at the practice level. Sample size is…”
Get full text

Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis by Koo, Sophia, Bryar, Julie M., Baden, Lindsey R., Marty, Francisco M.

Get full text

Diagnostic Performance of the (1^sub i^3) [beta]-d-Glucan Assay for Invasive Fungal Disease by Koo, Sophia, Bryar, Julie M, Page, John H, Baden, Lindsey R, Marty, Francisco M

“…Diagnosis of invasive fungal disease (IFD) is challenging, and it remains a significant cause of morbidity and mortality in immunocompromised patients. The…”
Get full text